Evalution the Safety and Efficacy in Atopic Dermatitis Patients

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD)

NCT01927705 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

NCT03252340 ·Status: COMPLETED

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT06397911 ·Status: RECRUITING ·Phase: PHASE2

Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

NCT04137562 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Evaluate the Use of RHT-3201 in SCORAD Reduction in Young Patients With Atopic Dermatitis

NCT03907228 ·Status: UNKNOWN ·Phase: NA

Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis

NCT04283968 ·Status: UNKNOWN ·Phase: PHASE3

KM110329 in Adult Patients With Atopic Dermatitis

NCT01692093 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis

NCT06012812 ·Status: COMPLETED ·Phase: PHASE2

A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis

NCT07321951 ·Status: RECRUITING ·Phase: PHASE2

Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis

NCT04613037 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children

NCT03826901 ·Status: COMPLETED ·Phase: PHASE1

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

NCT06389136 ·Status: RECRUITING ·Phase: PHASE3

Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis

NCT02888704 ·Status: COMPLETED ·Phase: PHASE1

Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study

NCT04936113 ·Status: TERMINATED ·Phase: PHASE2

A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis

NCT03096223 ·Status: COMPLETED ·Phase: PHASE1

Dupilumab Impact on Skin Resident Memory T Cells

NCT03983460 ·Status: UNKNOWN ·Phase: NA

A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis

NCT07158151 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis

NCT03912259 ·Status: COMPLETED ·Phase: PHASE3

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

NCT03989206 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis

NCT06931990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis

NCT01385657 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis

NCT04504279 ·Status: COMPLETED ·Phase: PHASE2

Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis

NCT05059509 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis

NCT03747575 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis

NCT00832585 ·Status: COMPLETED ·Phase: PHASE4